Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Medtronic plc (MDT) Common Stock USD0.0001

Sell:$105.22 Buy:$105.23 Change: $0.73 (0.70%)
Market closed |  Prices as at close on 23 October 2019 | Switch to live prices |
Change: $0.73 (0.70%)
Market closed |  Prices as at close on 23 October 2019 | Switch to live prices |
Change: $0.73 (0.70%)
Market closed |  Prices as at close on 23 October 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Contact details

20 On Hatch, Hatch Street Lower
+353 (1) 4381700

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$143.05 billion
Shares in issue:
1.34 billion
Health Care Equipment
New York Stock Exchange
US dollar

Key personnel

  • Omar Ishrak
    Chairman of the Board, Chief Executive Officer
  • Karen Parkhill
    Chief Financial Officer, Executive Vice President
  • Carol Surface
    Chief Human Resource Officer, Senior Vice President
  • Michael Coyle
    Executive Vice President, Group President - Cardiac and Vascular Group
  • Hooman Hakami
    Executive Vice President and Group President of the Diabetes Group
  • Robert ten Hoedt
    Executive Vice President and President - EMEAC
  • Geoffrey Martha
    Executive Vice President and President - Restorative Therapies Group
  • Robert White
    Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group
  • Richard Kuntz
    Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
  • Bradley Lerman
    Senior Vice President, General Counsel, Corporate secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.